Cision PR Newswire

RiboX Therapeutics Announces FDA IND Clearance for RXIM002, the first Circular RNA-Based in vivo CAR Therapy for Autoimmune Cytopenias

The FDA IND clearance supports the initiation of RiboX's Phase 1 clinical trial evaluating targeted LNP-delivered circular RNA-based in vivo CAR-T therapy for autoimmune cytopenias. RXIM002 represents the world's first circular RNA-based in vivo CAR-T therapy achieving FDA IND clearance. RiboX expands its clinical-stage pipeline through its proprietary...

Green Agriculture Chain Section at the 4th CISCE: AI-Driven Innovation Across Global Agri-Food Supply Chains

BEIJING, June 26, 2026 /PRNewswire/ -- The Green Agriculture Chain section of the fourth China International Supply Chain Expo (CISCE) brought together more than...

Sunwoda Launches Next-Generation 588Ah-Based ESS Platform at ees Europe 2026 and Announces Safety and EU Compliance Milestones

MUNICH, June 26, 2026 /PRNewswire/ -- Sunwoda, a full-scenario energy storage solution provider, participated in ees Europe 2026 in Munich, Germany, showcasing a broad...

Hong Kong’s Largest Home Exhibition “In-Home Expo 2026” Opens Today

Upgraded Senior Living Pavilion Debuts with AI Smart Elderly Care Technology as Key Highlight HONG KONG, June 25, 2026 /PRNewswire/ -- Organised by...

Action Energy Co. Appoints Kuwait Investment Company as Market Maker to Enhance Share Liquidity

KUWAIT CITY, June 25, 2026 /PRNewswire/ -- Action Energy Company K.S.C.P. (Bloomberg: ALFTAQA KK) (Reuters: ALFTAQA.KW) (Premier Market of Boursa Kuwait: ALFTAQA), Kuwait's leading...